These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37759294)

  • 1. Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.
    Xue W; Qiu K; Dong B; Guo D; Fu J; Zhu C; Niu Z
    Cancer Cell Int; 2023 Sep; 23(1):218. PubMed ID: 37759294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms.
    Chi H; Huang J; Yan Y; Jiang C; Zhang S; Chen H; Jiang L; Zhang J; Zhang Q; Yang G; Tian G
    Front Mol Biosci; 2023; 10():1254232. PubMed ID: 37916187
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.
    Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma.
    Chen P; Yu J; Luo Q; Li J; Wang W
    BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma.
    Wang K; Yu J; Xu Q; Peng Y; Li H; Lu Y; Ouyang M
    Apoptosis; 2024 Dec; 29(11-12):2074-2090. PubMed ID: 39115621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma.
    Yao H; Liu P; Yao L; Li X
    Cancer Cell Int; 2024 May; 24(1):183. PubMed ID: 38802854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
    Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialylation-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in uterine corpus endometrial carcinoma.
    Chen J; Wu T; Yang Y
    Cancer Cell Int; 2024 Sep; 24(1):314. PubMed ID: 39261877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
    Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z
    Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.
    Kang K; Li X; Peng Y; Zhou Y
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma.
    Zhu Y; Jin X; Liu J
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38639274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive identification of a disulfidptosis-associated long non-coding RNA signature to predict the prognosis and treatment options in ovarian cancer.
    Liu S; Jiang R; Wang X; Zhang Q; Li S; Sun X; Feng Y; Du F; Zheng P; Tian Y; Li Z; Liu S
    Front Endocrinol (Lausanne); 2024; 15():1434705. PubMed ID: 39345881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of disulfidptosis- and cuproptosis-related LncRNAs in modulating the immune microenvironment and chemosensitivity in colon adenocarcinoma.
    Fan Q; Wu GB; Chen M; Zheng L; Li HJ; Xiang LZ; Luo M
    IET Syst Biol; 2024 Apr; 18(2):55-75. PubMed ID: 38458989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
    Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
    Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.